Rare variants in neuronal excitability genes influence risk for bipolar disorder
- 17 February 2015
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 112 (11) , 3576-3581
Abstract
We sequenced the genomes of 200 individuals from 41 families multiply affected with bipolar disorder (BD) to identify contributions of rare variants to genetic risk. We initially focused on 3,087 candidate genes with known synaptic functions or prior evidence from genome-wide association studies. BD pedigrees had an increased burden of rare variants in genes encoding neuronal ion channels, including subunits of GABAA receptors and voltage-gated calcium channels. Four uncommon coding and regulatory variants also showed significant association, including a missense variant in GABRA6. Targeted sequencing of 26 of these candidate genes in an additional 3,014 cases and 1,717 controls confirmed rare variant associations in ANK3, CACNA1B, CACNA1C, CACNA1D, CACNG2, CAMK2A, and NGF. Variants in promoters and 5′ and 3′ UTRs contributed more strongly than coding variants to risk for BD, both in pedigrees and in the case-control cohort. The genes and pathways identified in this study regulate diverse aspects of neuronal excitability. We conclude that rare variants in neuronal excitability genes contribute to risk for BD. Significance Bipolar disorder (BD) is a common, severe, and recurrent psychiatric disorder with no known cure and substantial morbidity and mortality. Heritable causes contribute up to 80% of the lifetime risk for BD. Common genetic variation explains ∼25% of this heritable risk. Rare genetic variants may explain additional risk. We identified contributions of rare variants to BD by sequencing the genomes of 200 individuals from 41 families with BD. The two main findings of this study were as follows: rare risk variants for BD were enriched in genes and pathways that regulate diverse aspects of neuronal excitability; and most of these risk variants were noncoding with predicted regulatory functions. These results highlight specific hypotheses for future research and potential therapeutic targets.Keywords
Funding Information
- HHS | NIH | National Institute of Mental Health (P50 GM076547)
- HHS | NIH | National Institute of Mental Health (R01 MH094483)
- HHS | NIH | National Institute of Mental Health (Intramural)
- Gordon and Betty Moore Foundation (Fellow of the Life Sciences Research Foundation)
This publication has 46 references indexed in Scilit:
- Mutations in NOTCH1 Cause Adams-Oliver SyndromeThe American Journal of Human Genetics, 2014
- Diffuse angiopathy in Adams‐Oliver syndrome associated with truncating DOCK6 mutationsAmerican Journal of Medical Genetics Part A, 2014
- A population-based study of KCNH7 p.Arg394His and bipolar spectrum disorderHuman Molecular Genetics, 2014
- RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorderMolecular Psychiatry, 2014
- Cell Fates as High-Dimensional Attractor States of a Complex Gene Regulatory NetworkPhysical Review Letters, 2005
- The epidemiology of mood disordersCurrent Psychiatry Reports, 2004
- Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorderInternational Journal of Neuropsychopharmacology, 2003
- Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT GeneScience, 2003
- GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar DisorderNeuropsychopharmacology, 2001
- Calcium channel antagonists for the treatment of bipolar disorderBipolar Disorders, 2000